Skip to main content
Equibles

SOPH · SOPHiA GENETICS SA

Track SOPH — free

Use SOPH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.09 -0.21 (-2.53%) At close · Sep 4
Rebalance outlook locked
Market Cap
$688.68M
Shares
85.13M

SOPH metrics

63 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.09
Market cap
$688.68M

Price action

19 metrics
Price change (1W)
-0.6%
Price change (30D)
+5.5%
Price change (3M)
+61.8%
Price change (6M)
+86.0%
Price change (YTD)
+73.2%
Price change (1Y)
+137.2%
Trailing year
Price change (5Y)
-58.4%
52-week high
$8.92
52-week low
$3.12
Change from 52-week high
-9.3%
Change from 52-week low
+159.3%
Annualized volatility
70.4%
Beta
1.5
RSI (14D)
56.1
Price vs SMA 50
+18.9%
Price vs SMA 200
+50.5%
Avg volume (3M)
428,730
Relative volume
0.3
Average dollar volume
$2.92M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
85.13M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
9.9×
reciprocal yield 10.1%
P / book
14.6
reciprocal yield 6.8%
FCF yield
-5.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
67.8%
Operating margin
-96.6%
Trailing 12 months
Net margin
-105.3%
Gross profit (TTM)
$47.23M
Operating profit (TTM)
−$67.33M
Net income (TTM)
−$73.39M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-55.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.69

Growth

11 metrics
Revenue growth YoY
+15.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$69.69M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
+17.6%
Revenue CAGR (5Y)
+22.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-95.7%
Return on assets
-41.3%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$38.68M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$70.29M
Total assets
$163.03M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$38.42M
Capital expenditures (TTM)
$263,000
R&D (TTM)
$34.63M
SG&A (TTM)
—
Stock compensation (TTM)
$16.88M
R&D / revenue
49.7%
Stock compensation / revenue
24.2%

Ownership (13F)

3 metrics
13F filers
72
13F filer change QoQ
+22
Institutional ownership
43.8%

Short interest

3 metrics
Short interest
1.1%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.99M
Insider-sentiment score
61 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1840706 CUSIP H82027105 13F (30d) 46 filings 46 filers Visit website Investor relations